Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Analysis of Pt-Level Data From SWOG-1216 Phase 3 Trial - Outcomes of Black vs. White Patients With mHSPC Treated With ADT With or Without Orteronel"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Nicolas Sayegh
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Nicolas Sayegh
Login to view comments.
Click here to Login